![Keith Regnante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Regnante
Plus aucun poste en cours
Fortune : 108 373 $ au 31/08/2026
Profil
Mr. Keith C.
Regnante is a Chief Financial Officer at City Therapeutics, Inc. Mr. Regnante was previously employed as a Chief Financial Officer by Keros Therapeutics, Inc., a Chief Financial & Accounting Officer by WAVE LIFE SCIENCES LTD, a Vice President-Finance by Shire Pharmaceuticals, Inc., a Head-Research & Development Finance by ARIAD Pharmaceuticals, Inc., and a Senior Director-Corporate Finance by Biogen Idec, Inc. He received his undergraduate degree from Tufts University and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 9 781 ( 0,05% ) | 108 373 $ | 31/08/2026 |
Postes actifs de Keith Regnante
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Keith Regnante
| Sociétés | Poste | Fin |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Directeur Financier/CFO | 03/08/2026 |
| WAVE LIFE SCIENCES, INC. | Directeur Financier/CFO | 09/01/2020 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/08/2016 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2014 |
| BIOGEN INC. | Public Communications Contact | 01/08/2013 |
Formation de Keith Regnante
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
